Bifidobacterium breve MCC 1128

Bifidobacterium breve MCC 1128 is a Gram-positive, anaerobic bacterium belonging to the genus Bifidobacterium, which is commonly recognized for its role in the human gut microbiota. This microbe is characterized by its inability to survive in oxygen-rich environments, making it an obligate anaerobe. Bifidobacterium species, including B. breve MCC 1128, are often associated with beneficial health effects, particularly in infant and adult gut health, where they contribute to maintaining a balanced microbiome. As a member of the Bifidobacteriaceae family, B. breve MCC 1128 is likely to exhibit fermentative metabolism, utilizing carbohydrates as a primary energy source while producing short-chain fatty acids, such as acetate and lactate, which can be beneficial for gut health. These metabolic products may also play a role in modulating the host immune response and maintaining intestinal homeostasis. The specific strain MCC 1128 has been isolated for its potential probiotic properties, which may include the ability to inhibit pathogenic bacteria and enhance gut barrier functions. Given its anaerobic nature, Bifidobacterium breve MCC 1128 thrives in the gastrointestinal tract, where it may outcompete other microbial species for resources, thereby supporting overall microbial diversity. Further studies may elucidate its specific interactions within the gut environment and its contributions to host health and disease prevention.